Gene: ACSM2A
Official Full Name: acyl-CoA synthetase medium chain family member 2Aprovided by HGNC
Gene Summary: This gene encodes a mitochondrial acyl-coenzyme A synthetase that is specific for medium chain fatty acids. These enzymes catalyze fatty acid activation, the first step of fatty acid metabolism, through the transfer of acyl-CoA. These enzymes also participate in the glycine conjugation pathway in the detoxification of xenobiotics such as benzoate and ibuprofen. Expression levels of this gene in the kidney may be correlated with kidney function. This gene and its paralog ACSM2B (Gene ID: 348158), both present on chromosome 16, likely arose from a chromosomal duplication event. [provided by RefSeq, May 2017]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA05329 | ACSM2A Knockout cell line (AC16) | Human | ACSM2A | 1:3-1:4 | negative | Online Inquiry |
| KOA20774 | ACSM2A Knockout cell line (BEAS-2B) | Human | ACSM2A | 1:3~1:4 | negative | Online Inquiry |
| KOA36218 | ACSM2A Knockout cell line (U-2932) | Human | ACSM2A | 1:2-1:4 | negative | Online Inquiry |
| KOA51628 | ACSM2A Knockout cell line (TPC-1) | Human | ACSM2A | 1:5-1:8 | negative | Online Inquiry |
| KOA67034 | ACSM2A Knockout cell line (NCM460) | Human | ACSM2A | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.